Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
Breast Neoplasms
×
neratinib
×
Clear all
Filters
3
NCT04901299
2023-08-01
HER2-Signal
Massachusetts General Hospital
Phase 2
Withdrawn
NCT04856475
2022-03-02
NeraBrain
Jules Bordet Institute
Phase 2
Withdrawn